BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bonnet E, Mastier C, Lardy-Cléaud A, Rochefort P, Sarabi M, Guibert P, Cattey-Javouhey A, Desseigne F, de La Fouchardière C. FOLFIRINOX in patients with peritoneal carcinomatosis from pancreatic adenocarcinoma: a retrospective study. Curr Oncol 2019;26:e466-72. [PMID: 31548814 DOI: 10.3747/co.26.4903] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Gao L, Xu Z, Huang Z, Tang Y, Yang D, Huang J, He L, Liu M, Chen Z, Teng Y. CPI-613 rewires lipid metabolism to enhance pancreatic cancer apoptosis via the AMPK-ACC signaling. J Exp Clin Cancer Res 2020;39:73. [PMID: 32345326 DOI: 10.1186/s13046-020-01579-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
2 Rijken A, Bakkers C, van Erning FN, van der Geest LG, de Vos-Geelen J, Besselink MG, Lemmens VE, de Hingh IHJT; Dutch Pancreatic Cancer Group. Incidence, Treatment, and Survival of Synchronous Peritoneal Metastases in Pancreatic Cancer: Update of a Nationwide Cohort. Pancreas 2021;50:827-33. [PMID: 34347730 DOI: 10.1097/MPA.0000000000001857] [Reference Citation Analysis]
3 Mohindroo C, Hasanov M, Rogers JE, Dong W, Prakash LR, Baydogan S, Mizrahi JD, Overman MJ, Varadhachary GR, Wolff RA, Javle MM, Fogelman DR, Lotze MT, Kim MP, Katz MHG, Pant S, Tzeng CD, McAllister F. Antibiotic use influences outcomes in advanced pancreatic adenocarcinoma patients. Cancer Med 2021;10:5041-50. [PMID: 34250759 DOI: 10.1002/cam4.3870] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]